Dundee Corporation Sells 8,000 TauRx Shares for $1 Million

The transaction, pending board approval, reduces Dundee's holding in TauRx Pharmaceuticals to 1,007,008 shares.

• Dundee Corporation announced the sale of 8,000 shares of TauRx Pharmaceuticals Ltd. for a total of US$1 million.
• The shares were sold to a private investor at a price of US$125 per share.
• The transaction is subject to approval by the board of TauRx Pharmaceuticals.
• Following the sale, Dundee Corporation will retain 1,007,008 shares in TauRx.
• Dundee Corporation is a Canadian independent holding company with a focus on long-term investments in the mining sector.

3 Articles

The Canadian Press Financial Post Benzinga